Health Care Equipment and Supplies
More
-
*Europe revisits rules after breast, hip implant scandals. LONDON, Feb 20- One year on from a breast implant scandal that shook confidence in Europe's light-touch system for regulating medical devices, lawmakers and manufacturers are at loggerheads on ways to protect patients from shoddy products.
-
"In the patients that have been implanted to date, the improvement in the quality of life has been invaluable," said Mark Humayun of the University of Southern California's Keck School of Medicine and USC's Viterbi School of Engineering, who helped develop the device.
-
The device, made by privately held Second Sight Medical Products Inc of Sylmar, California, consists of a special pair of glasses outfitted with a video camera and a video processing unit that sends signals to a wireless receiver implanted in the eye.
-
*To add 2 cents to 3 cents to 2013 EPS, at least 18 cents in FY14. Feb 14- U.S. drug wholesaler Cardinal Health Inc said it plans to acquire AssuraMed, a privately held direct-to-home medical supply distributor, for about $2.07 billion.
-
*Rocky Mount plant back to capacity in 2013- Hospira. Feb 13- Hospira Inc, a hospital products maker that has grappled with regulatory issues at manufacturing plants for the past 18 months, said it had received a notice over the quality of its medical devices from the U.S. Food and Drug Administration.
-
*Rocky Mount plant back to capacity in 2013- Hospira. Feb 13- Hospira Inc, a hospital products maker that has grappled with regulatory issues at manufacturing plants for the past 18 months, said it had received a notice over the quality of its medical devices from the U.S. Food and Drug Administration.
-
A sharp and surprisingly persistent slowdown in the growth of health care costs is helping to narrow the federal deficit, leaving budget experts trying to figure out whether the trend will last.
-
*Fiscal 2013 forecast tightened to $3.42- $3.50 a share. Net earnings in the second quarter ended Dec. 31 rose to $303 million, or 88 cents a share, from $262 million, or 75 cents a share, a year earlier, the company said on Tuesday.
-
Feb 5- Becton Dickinson and Co reported higher-than-expected quarterly earnings on Tuesday, boosted by an early flu season, and the medical device and instrument company raised its outlook for the full year. Net earnings were $625.4 million, or $3.13 per share, in the first quarter ended Dec. 31, compared with $263.0 million, or $1.21 per share, a year earlier.
-
*Fiscal 2013 forecast tightened to $3.42- $3.50 a share. Net earnings in the second quarter ended Dec. 31 rose to $303 million, or 88 cents a share, from $262 million, or 75 cents a share, a year earlier, the company said on Tuesday.
-
Feb 5- Drug wholesaler Cardinal Health Inc said on Tuesday that quarterly earnings had risen 16 percent, driven by increased sales of generic medicines and medical products such as surgical gowns and instruments. Net earnings in the second quarter ended Dec. 31 rose to $303 million, or 88 cents a share, from $262 million, or 75 cents a share, a year earlier.
-
*Q4 profit of 90 cents excluding items tops analysts' 77 cents view. Feb 4- Edwards Lifesciences Corp on Monday posted fourth-quarter earnings that beat analyst expectations on strong sales of its replacement heart valve that is implanted in a less-invasive procedure than open-heart surgery.
-
*FDA: insufficient evidence for metals/health correlation. LOS ANGELES, Feb 1- Toxicity caused by debris from a metal-on-metal hip implant meant that the device had to be removed from a 66- year-old man who is suing manufacturer Johnson& Johnson, according to expert testimony heard at the trial on Friday.
-
*Fourth-quarter net income falls to 4 cents a share from 7 cents. Jan 29- Boston Scientific Corp reported weaker quarterly earnings on Tuesday as sales slipped and expenses rose, and the medical device maker announced more job cuts. Boston Scientific employs 24,000 workers worldwide, according to its website.
-
*Fourth-quarter net income falls to 4 cents a share from 7 cents. Jan 29- Medical device maker Boston Scientific Corp posted weaker quarterly earnings on Tuesday as sales slipped and expenses rose. Fourth-quarter net earnings were $60 million, or 4 cents per share, down from $107 million, or 7 cents per share, a year earlier.
-
Los Angeles, Jan 25- Johnson& Johnson was aware of defects when it started selling its now-recalled metal hip implants in 2004, lawyers said on Friday during opening arguments in a personal injury trial against the company. The suit was filed in California Superior Court by 66- year-old Loren Kransky, whose ASR hip was replaced early last year.
-
*4th- qtr profit 89 cents/ share vs 82 cents a year ago. Jan 24- Medical device and bioscience company Baxter International Inc reported higher quarterly earnings on Thursday and forecast sales growth of 10 percent for 2013..
-
*Profit ex-items of $1.14/ shr tops estimates by 2 cts. *Continues to see 2013 earnings of $4.25 to $4.40 a share. Jan 23- U.S. orthopedic implant maker Stryker Corp on Wednesday reported fourth-quarter earnings excluding charges that exceeded analyst estimates as sales of its hip, knee and spine products improved.
-
Jan 18- Johnson& Johnson is negotiating a potential $2 billion settlement with patients who received its recalled artificial hip implant, Bloomberg News reported on Friday, citing five people familiar with the matter.
-
Jan 17- Medical device maker Stryker Corp said it will buy Hong Kong- based Trauson Holdings Co Ltd for $764 million in cash to expand in China, one of the fastest-growing markets for orthopaedic products. Founded in China in 1986, orthopaedics firm Trauson had sales of about $60 million in 2011 and makes spine devices and products for trauma surgeries.